Supply Chain Council of European Union |

Governments may onshore part of biopharma supply chain, but it won’t be easy: Panel, Companies & Markets


THE Covid-19 pandemic has exposed vulnerabilities in the global biopharmaceutical supply chain, raised renewed concerns over the offshoring of facilities to Asia and highlighted the heavy reliance on large producer markets – such as China and India – for critical medical…

Related posts

Laparoscopic Devices Market Research Key Players, Industry Overview, Supply Chain and Analysis to 2020-2026 – Medic Report


Ruest driving CN deeper into consumer supply chain


Ex-Amazon and Zulily supply chain vets raise $2M for Seattle e-commerce logistics startup Shipium – GeekWire


Leave a Comment